Adam Koppel, Director of Kailera Therapeutics KLRA, has filed 2 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $25M. The latest trade was on 04/20.

AK

AK

Adam Koppel

Director

Company

Kailera Therapeutics KLRA

First filing

23/06/08

Trades

19 trades

Buys / sales

2 / 0

12-month net buying

$25M

Last trade

04/20

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Kailera TherapeuticsKLRA	Open-market buy	04/20	04/20	1,562,500 sh	$16.00	$25,000,000	+7.4%
CH Cerevel Therapeutics Holdings	Open-market buy	23/10/16	23/10/18	5,480,052 sh	$22.81	$124,999,986.12	+9.1%